EDIT Q1 2025 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+310.4% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$76M-1635.1% margin

Net Income

-$76M-1633.5% margin

EPS (Diluted)

$-0.92

QoQ Revenue Growth

-84.8%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$48M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$264M

Total Liabilities

$201M

Stockholders' Equity

$62M

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$1M	+310.4%
Gross Profit	$5M	-$274,000	+1800.0%
Operating Income	-$76M	-$67M	-13.7%
Net Income	-$76M	-$62M	-22.8%

Revenue Segments

Reportable Segment

$5M100%